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4Brief Description:
Although the AIDS epidemic in America began approximately three decades ago, much remains 
to be learned about the epidemiology of human immunodeficiency virus (HIV) infections in rural 
America. This study compared profiles of HIV patients at the James H. Quillen Veterans Affairs 
Medical Center (VAMC) in Mountain Home, TN to those seen at a university-based community 
HIV care clinic (COM) in Johnson City, TN.
Key Points: 
1. The typical patient demographic profile in the COM includes Caucasian males whose 
major risk factor for HIV infection is men having sex with men (MSM). 
2. Compared to the COM, the VAMC patient profile was significantly older, more male, 
more heterosexual, more African-American, and had more users of cocaine and alcohol. 
3. Co-infection with hepatitis C was significantly greater in the VAMC population in the 
univariate analysis. This is likely a reflection of the higher incidence of cocaine use 
among VAMC patients. 
4. Two indicators of disease progression were tracked.  Host CD4 cells increased from first 
to last clinic visit in both populations, but the rate of increase was significantly greater in 
COM patients.  Viral loads showed significant and similar rates of decrease in both 
patient populations. 
Key Words: 
HIV; rural America; rural VAMC; co-morbidities; co-infections; habits posing potential health 
risks 
5In the United States, HIV was first described in 1981. At that time, HIV seemed to be 
localized to certain large urban areas with apparent sparing of persons in rural areas. However, as 
early as 1988, rural physicians noted that HIV/AIDS was spreading from urban to rural areas.
1
Regardless of where studies were conducted throughout rural America, one finding remained 
constant: HIV/AIDS spread to rural areas in “two ‘waves.’” 
2
The first wave consisted of 
individuals with HIV/AIDS who located from urban to rural areas to receive social support, 
especially from family, and/or to seek work, other educational opportunities, and even end-of-
life support.
2-4 
During the late 1980s, Southern Appalachia family, church, and community 
responses to a 32-year-old homosexual white man were unexpectedly and unpredictably kind. 
This community response was not uncommon but shared by a number of other patients, though 
certainly not all. However, this particular study cites family and community support as more 
important factors of preparing a community for HIV/AIDS than attempts at education.
3
 By 1995, 
it was proposed that this “returning home” phenomenon may be universal, at least among 
homosexuals.
5
 Whatever the reason, it is this phenomenon that was largely responsible for the 
first wave of AIDS in rural America. 
 The second, or “‘home grown,’” wave in the United States is largely composed of 
individuals who became infected with HIV while living in rural areas.
2
 Locally acquired 
infections tend to be transmitted mostly via sexual activity—especially heterosexually—, but 
other associated factors may include drug use and prevalence of sexually transmitted diseases.
1, 2,
6, 7
 This home grown group largely consists of young, non-white women.
2, 4, 6
While the spread of HIV/AIDS to rural areas was noted not long after the AIDS epidemic 
began, little research has been conducted on the “face” of HIV in rural America. As recently as 
6five years ago, a study noted that “little information is available on the burden of HIV disease, 
including HIV infection without AIDS, in…rural communities.” 
7
Because most of the research 
on HIV infection in rural America has focused on separate regions instead of the nation as a 
whole, it is nearly impossible to derive generalizations concerning the demographic 
characteristics associated with local rural HIV infections, as these infections tend to be highly 
region-specific. That is, not all rural areas are similar. For example, studies have been conducted 
on  HIV/AIDS populations within the University of North Carolina Hospitals,
4
the Appalachian 
Region,
3, 7
 the US-Mexico Border,
5, 7
 the Mississippi Delta, the Southeast Region,
7
 and an 
American Indian population in the rural Southwest.
8
 A multi-state HIV/AIDS study including 
participants from rural areas and small cities in Georgia, Florida, South Carolina, and Delaware 
has also been conducted.
2
One reason these are all focused on the southern United States is that 
this region “accounts for the largest overall burden of [HIV/AIDS], particularly in rural areas.” 
2
However, in addition to studies in this region, a study was conducted that focused on examining 
where HIV-infected people in America live and, specifically, how many live in rural America.
1
Regional variances are observed among these studies. 
Although many community HIV/AIDS clinics in America adhere to standards of care, 
treatment of veterans with HIV/AIDS who seek care at a Veterans Affairs Medical Center is 
regulated by a number of protocols established by the Department of Veterans Affairs (VA). 
While the U.S. Armed Forces have tested all personnel on active duty for HIV/AIDS since 1985, 
and found that, for over two decades, incidence of HIV among military men and women has 
remained stably low, the VA “cares for >20,000 patients with HIV infection, providing >1 
million outpatient clinic visits and 170,000 days of hospital care, making it the single largest 
provider of HIV care in the United States.” 
9
 As such, many early HIV-related clinics were 
7started on VA campuses, and approximately 50,000 veterans with HIV/AIDS have been treated 
at a VA facility since 1981.
9
In a study investigating the organization and management of HIV/AIDS care offered at 
VA facilities, representatives from 118 facilities (out of 138 facilities that had directly cared for 
at least one HIV/AIDS patient in the 1999 fiscal year) responded. Eighty-two percent of the 
sample was comprised of urban VA facilities, which parallels the fact that most veterans live in 
urban areas. These same facilities were reported as having a significantly higher number of HIV 
caseloads than their rural counterparts.
9
As a rule established by the VA, “all HIV-infected 
subjects have access to comprehensive primary care and to all available antiretroviral drugs.” 
10
However, since rural VAs are limited in their access to specialty care—as is the case in nearly all 
rural areas—most rural VAs refer patients to either other VAs or to primary care providers. 
Despite this, rural VA clinics are noted to “have accomplished their mission with comparable 
chronic disease and prevention performance and higher patient satisfaction, compared with their 
urban counterparts. However, it is not known whether patients who are treated for HIV disease in 
rural VA settings enjoy similar benefits” although it is known that HIV/AIDS patients in rural 
communities are less likely to receive prophylaxis for Pneumocystis pneumonia (PCP) or to 
receive Highly Active Antiretroviral Therapy (HAART).
9
While, at the time of this study, 
variation in treatment rates between urban and rural VAs had not been calculated, the study 
confirmed three significant differences in the two facility types: “rural VAs had much lower HIV 
caseloads, had less access to needed HIV expertise, and, not surprisingly, tended to mainstream 
HIV care.”
 9
8While it is known that significant differences in populations of HIV/AIDS patients exist 
between urban and rural areas and among urban and rural VA facilities and rural community 
clinics, to our knowledge, no attempts have been made at comparing rural VA and rural 
community HIV/AIDS clinics. Therefore, the purpose of this study was to create and compare 
profiles of a rural VA HIV clinic and a rural community HIV clinic in order to determine what, if 
any, characteristics are more associated with HIV patients in one setting versus the other. 
Additionally, a comparison of these results was made to other studies that focused on HIV/AIDS 
in rural America. 
Methods
East Tennessee State University’s (ETSU) James H. Quillen College of Medicine located 
in Johnson City, TN received designation as an HIV/AIDS Center of Excellence in 1999. As part 
of the Tennessee HIV Centers of Excellence project, ETSU developed a community HIV clinic 
(COM), which offers “a standardized and coordinated delivery system, encompassing a 
comprehensive range of services needed by individuals or families with HIV disease to meet 
their health care and psychosocial service needs throughout all stages of the illness.” 
11
To be 
designated and remain as such, certain criterion have to be met, including “expertise in 
HIV/AIDS care, standardized procedures, linkage with AIDS service organizations, social 
services and case management, available referral services, available ancillary services, increased 
access to care, optimal level of services, participation with managed care organizations, and a 
research component.”
 11 
Approximately 500 patients benefit from services offered by the COM, 
most of who are from the Tri-Cities and surrounding region. Funded by grants from the state of 
Tennessee Department of Health and Human Services and the Ryan White Care Act, the COM is 
9able to offer a range of services to their patients that include but are not limited to “medical care 
management, assistance with social service needs, use of current HIV/AIDS standardized 
treatment [guidelines], care managed by experts, increased focus on research, a system that 
responds quickly to changes in technology, focus on prevention of opportunistic infection, 
increased access to clinical trials, inappropriate treatment reduced or eliminated, and finally a 
treatment environment that is patient and provider friendly.” 
11
While it is part of an entirely different health care system, the Division of Infectious 
Diseases at James H. Quillen Veterans Affairs Medical Center (VAMC) located in Mountain 
Home, TN includes the same physicians who provide HIV care at the COM. Therefore, the care 
and benefits provided by the two clinics is practically identical, as are the numbers of patients 
served: The COM clinic serves patients who reside in approximately 150 surrounding counties, 
while the VAMC serves over 170,000 veterans who live within 41 counties dispersed throughout 
east Tennessee, southeast Kentucky, southwest Virginia, and west North Carolina.
12
Both clinics are in Washington County, TN, which is part of the TN-VA metropolitan 
statistical area (MSA). As of 2009, the United States Census Bureau reported that the TN-VA 
combined statistical area (CSA) (comprised of Johnson City, Kingsport, and Bristol, TN and 
Bristol, VA) contained 503,010 residents. The Johnson City MSA alone accounted for 197,381 
of these residents, while the Kingsport-Bristol, TN-Bristol, VA MSA accounted for 305,629.
13
 It 
is also notable that, as of 2009, African-Americans were recorded as comprising 4.1% of the 
Washington County population and 16.8% of the state of Tennessee while Caucasians were 
noted to compose 93.8% and 80.2% of those populations, respectively.
14 
Many HIV-infected 
10
persons who reside in these and surrounding areas are patients at either the VAMC or COM 
clinic. 
 All patients with HIV infection at the VAMC and a sampling of COM HIV-infected 
persons for the years 2000-2009 were included in the study. The sample included 99 VAMC 
patients and 100 COM patients. All data were obtained via retrospective medical record review.
The following data were collected and recorded for each patient:  
x Age at first visit 
x Gender
x Race
x Birthplace
x Current residence 
x Heterosexuality (Because there were no records in patients’ charts about how 
many sexual partners they had and/or whether those partners were high-risk, 
heterosexual HIV transmission was considered a demographic variable instead of 
a risk factor.) 
x Risk factors (n = 3; men having sex with men [MSM], intravenous drug use 
[IVDU], and receiving a blood transfusion) (Note: Patients were not identified as 
either homosexual or bisexual but as having the risk factor of MSM in an attempt 
to reduce the possibility of inaccurate self-reporting.) 
x Habits posing potential health risks (n = 6; use of cocaine, marijuana, alcohol, 
narcotics, and tobacco, and participation in habits categorized as “other,” 
including prostitution, use of methamphetamine, and overuse of caffeine or 
prescription drugs)
x Co-morbidities (n = 32; psychiatry disorder, PTSD, CAD, MI, CHF, CVA/TIA, 
COPD, asthma, hypertension, hyperlipidemia, DM, cirrhosis of liver/liver failure, 
chronic renal failure/CRI, pancreatitis, lung cancer, colon cancer, 
leukemia/lymphoma/hematologic malignancy, anemia, seizure, connective tissue 
disorder/RA/SLE.I, sexual dysfunction, HSV/HZV infection, 
11
cholecystitis/cholelithiasis/GB disease, OSA, psoriasis, BPH, GERD, erectile 
dysfunction, gout, radiculopathy, myopathy, and thrombocytopenia) 
x Co-infections (n = 3; hepatitis C, hepatitis B, and syphilis) 
x CD4 cell count and viral load at first and last visits (no later than December 31, 
2009)
x Where applicable, compliance to office visits each year for a consecutive three-
year period 
The study was approved by the joint ETSU/VA IRB. All data were de-identified prior to data 
analysis. 
To first explore the data for significant factors, univariate analysis was performed using 
chi square tests of goodness-of-fit when an a priori expectation existed (i.e., equal sex ratio).
Chi square tests for heterogeneity were performed on 2 x 2 contingency tables in which there 
were two sites (VAMC; COM) and two conditions (present; absent). Chi square tests were 
performed using the “frequency data” option on VassarStats: Website for Statistical 
Computation, as were calculations of odds ratios and relative risks for significant demographic 
variables and all other categorical variables, respectively.
15
 For demographic factors, odds ratios 
were presented because, by definition, an odds ratio compares the presence and absence of a 
factor; whereas, relative risk is concerned with the presence of a factor in a population. For the 
quantitative variable, age, a student t-test was performed.
15
Multivariate analysis was performed via logistic regression using SAS version 9.2.
16
 In 
the binary logistic regression, the response variable was clinic (VAMC or COM) with several 
binary predictor variables. To reduce the number of variables in the model, the entire dataset was 
evaluated, and instances in which a positive response for a variable (i.e., lung cancer) was 
observed only a few times or instances for which positive responses to variables were observed a 
12
similar number of times within each population were excluded. Then, forward stepwise selection 
was used with the STEPWISE SELECTION option in the PROC LOGISTIC procedure with an 
inclusion and removal criteria of 0.35. When two-way interactions were examined, none were 
significant in either the univariate or the multivariate model. Accordingly, none were included in 
the model. Model fit statistics—specifically AIC, SC, and -2 Log L—where lower values upon 
the addition of new variables are indicative of a more effective model were used to evaluate the 
efficiency of the models.  
For the quantitative variables, CD4 cell count and viral load at patients’ first and last 
visits, a repeated measures analysis of variance was performed using the PROC GLM procedure 
with the REPEATED MEASURES option in SAS version 9.2.
16
 In these analyses, the main 
effect was clinic (VAMC or COM), with CD4 cell counts or viral load counts as the repeated 
dependent variable.
Thus, all variables were included in analyses except for patients’ migration patterns and 
compliance to office visits for a consecutive three-year period, where data were available. No 
analyses were able to be performed on these measures due to time constraints. 
Results
Demographics
 The VAMC HIV patients were significantly older than COM patients (VAMC mean = 
50.0 years, s.d. = 8.84, range = 32 - 76 years; COM mean = 37.9 years, s.d. = 9.75, range = 16 -
67 years; t = 9.18, df = 197, P <0.0001). Both the VAMC and the COM populations were male 
biased (VAMC: F21:1 = 87.36, df = 1, P <0.0001; COM: F21:1 = 33.64, df = 1, P <0.0001), but, as 
13
expected, the VAMC population was significantly more strongly biased (heterogeneity F2 = 
15.15, df = 1, P = 0.0001), as 96% of the VAMC patients were males. In fact, VAMC patients 
were 8.51 times more likely to be male (Table 1). Both populations were strongly Caucasian (chi 
square test comparing the numbers of Caucasian to non-Caucasian patients: VAMC: F21:1 = 4.94, 
df = 1, P = 0.03; COM: F21:1 = 57.76, df = 1, P <0.0001). The VAMC population was also 
notably more strongly African-American (chi square test comparing the numbers of African-
American to non-African-American patients: VAMC: F21:1 = 4.94, df = 1, P = 0.03; COM: F21:1 = 
60.84, df = 1, P <0.0001). The patient population from the COM was more heavily Caucasian 
than that of the VAMC, as COM patients were 4.64 times more likely to be Caucasian (COM = 
88%, VAMC = 60%; F2 = 18.80, df = 1, P <0.0001) (Table 1).  Conversely, VAMC patients 
were more heavily African-American than COM patients, with VAMC patients being 5.12 times 
more likely to be African-American (VAMC = 38%, COM = 11%; F2 = 20.50, df = 1, P 
<0.0001) (Table 1). No other races were present in the VAMC population, and only one other 
race was present in the COM: 1% of COM patients were Hispanic. In addition to a more male 
biased population, the VAMC was more heterosexual biased, as VAMC patients were 4.09 times 
more likely to be heterosexual than were COM patients (COM = 27%, VAMC = 53%; F2 =
21.14, df = 1, P <0.0001) (Table 1).
14
Table1.DemographicsofVAMCandCOMHIVPatients
 VAMC* COM F Pvalue OddsRatio(VAMC:COM)
SexRatio     
Male 96 79
15.15 0.0001 8.5:1
Female 3 21
Race/Ethnicity    
Caucasian     
Yes 60 88
18.80 <0.0001 1:4.6No 38 12
AfricanͲAmerican     
Yes 38 11
20.50 <0.0001 5.1:1No 60 89
Hispanic     
Yes 0 1
0.96 1.00 _____No 98 99
Heterosexuality    
Yes 53 27
21.14 <0.0001 4.1:1
No 35 73
*ThenumbersofVAMCpatientsvaryfromtheclinictotalwithsomedemographicvariablesbecausetheinformationwas
unattainable.
Risk Factors 
 Although three risk factors were considered, only two showed significant differences 
between the VAMC and the COM (Table 2). Men having sex with men (MSM) was 1.59 times 
more likely to be associated with COM patients; while the VAMC population was nearly in a 1:1 
MSM to non-MSM ratio (F21:1 = 1.16, df = 1, P = 0.33), the COM population (F21:1 = 16.00, df = 
1, P <0.0001) was MSM biased (F2 = 12.65, df = 1, P <0.001) (Table 2). Both populations were 
biased toward non-IVDU (VAMC: F21:1 = 20.78, df = 1, P <0.0001; COM: F21:1 = 70.56; df = 1; 
P <0.0001), but the VAMC population was more prone to having IVDU as a risk factor than the 
COM (F2 = 10.93, df = 1, P = 0.001). In fact, IVDU was 3.23 times more likely to be associated 
with VAMC HIV patients (Table 2). 
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Table2.RiskFactorsofVAMCandCOMHIVPatients
 VAMC* COM** F Pvalue RelativeRisks(VAMC:COM)
MSM     
Yes 38 70
12.65 0.0006 1:1.6
No 48 30
IVDU     
Yes 23 8
10.93 0.001 3.2:1
No 66 92
BloodTransfusion    
Yes 4 2
1.72 0.23 _____
No 65 98
*ThenumbersofVAMCpatientsvaryfromtheclinictotalwitheachriskfactorbecausesomepatients'riskfactorswere
unknown.
**TwoCOMpatientshadnoriskfactorstoaccountfor,astheywerebornwithHIVinfection.
Habits 
 Six habits posing potential health risks were considered in this study, and four showed 
significant differences between clinics (Table 3). Patients from the VAMC were 4.15 times more 
likely to be cocaine users than those from the COM (F2 = 22.53, df = 1, P <0.0001) (Table 3). A 
similar frequency of occurrence was noted for marijuana use: the VAMC population was 1.78 
times more likely to consist of marijuana users (F2 = 4.88, df = 1, P = 0.03) (Table 3). 
Conversely, tobacco use was prevalent in both populations but was significantly more so in the 
VAMC, with VAMC patients being 1.38 times more likely to use tobacco (F2 = 15.06, df = 1, P 
= 0.0001) (Table 3). Interestingly, COM patients were 10 times more likely than VAMC patients 
to participate in habits categorized as “other” (F2 = 7.68, df = 1, P = 0.01) (Table 3). 
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Table3.HabitsofVAMCandCOMHIVPatients PosingPotentialHealth
Risks
 VAMC COM F Pvalue RelativeRisks(VAMC:COM)
CocaineUse    
Yes 37 9
22.53 <0.0001 4.2:1
No 62 91
MarijuanaUse    
Yes 30 17
4.88 0.03 1.8:1
No 69 83
AlcoholUse    
Yes 45 38
1.14 0.32 _____
No 54 62
NarcoticsUse    
Yes 8 3
2.47 0.13 _____
No 91 97
TobaccoUse    
Yes 86 63
15.06 0.0001 1.4:1
No 13 37
OtherHabits*    
Yes 1 10
7.68 0.01 1:10.0
No 98 90
*OtherHabitsincludeprostitution,useofmethamphetamine,andoveruseofprescriptiondrugsand
caffeine
Co-morbidities
 Thirty-two co-morbidities were considered, but in univariate analyses only six showed 
significant differences between the VAMC and the COM (Table 4). The twenty-six insignificant 
co-morbidities included various cancers, such as B-cell lymphoma, and diseases of the 
respiratory, circulatory, and urinary systems, among others, such as COPD, gall bladder disease, 
etc. Of the six significant results, three were expected. For example, Post-traumatic Stress 
Disorder (PTSD) was found only in the VAMC population, but a PTSD diagnosis would be 
unlikely in a COM patient, who would receive a diagnosis of a psychiatric disorder, though the 
symptoms could be similar. Therefore, occurrence of PTSD and psychiatric disorders were later 
17
compared by counting PTSD diagnoses as psychiatric disorder diagnoses. Eleven percent of 
VAMC patients had PTSD, and nine of those had been diagnosed with both PTSD and a 
psychiatric disorder. The remaining two patients had been diagnosed only with PTSD. 
Consequently, those two patients were counted as having psychiatric disorders for the purpose of 
analysis, and there was no statistical difference between the two clinics (F2 = 0.62, df = 1, P = 
0.46) (Table 4).
Similarly, the VAMC population had a significantly higher incidence of congestive heart 
failure (CHF) (F2 = 5.17, df = 1, P = 0.03) (Table 4). However, no VAMC patient was noted to 
have asthma, but, considering the difficulty a person suffering from asthma would have during 
military basic training, this result was also expected. Both populations were biased against 
asthma sufferers (VAMC: F21:1 = 99.00, df = 1, P <0.0001; COM: F21:1 = 67.24, df = 1, P 
<0.0001), but the VAMC population was even more biased against this co-morbidity than the 
COM population (F2 = 9.34, df = 1, P = 0.003) (Table 4). 
For the other co-morbidities that showed a significant difference between clinics, 
pancreatitis was 7.07 times more likely to occur in VAMC patients than in COM patients (F2 =
4.76, df = 1, P = 0.03) (Table 4). Conversely, thrombocytopenia was significantly more common 
in the COM (relative risk = 3.13:1 COM: VAMC; F2 = 6.32, df = 1, P = 0.02 (Table 4). 
Similarly, COM patients were significantly more likely to have herpes simplex and/or herpes 
zoster infections (relative risk = 1.69:1 COM: VAMC; F2 = 4.79, df = 1, P = 0.04) (Table 4).
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Table4.CoͲmorbiditiesofVAMCandCOMHIVPatients
 VAMC COM F Pvalue RelativeRisks(VAMC:COM)
Psychiatrydisorder*    
Yes 60 66
0.62 0.46 _____
No 39 34
PTSD*     
Yes 11 0
11.77 0.0003 f:1
No 88 100
CAD     
Yes 11 4
3.62 0.07 _____
No 88 96
MI     
Yes 1 1
1.26x10Ͳ4 1.00 _____
No 98 99
CHF     
Yes 5 0
5.17 0.03 f:1
No 94 100
CVA/TIA     
Yes 8 4
1.46 0.25 _____
No 91 96
COPD     
Yes 13 7
2.07 0.17 _____
No 86 93
Asthma     
Yes 0 9
9.34 0.003 1:f
No 99 91
Hypertension    
Yes 40 38
0.12 0.77 _____
No 59 62
Hyperlipidemia    
Yes 32 35
0.16 0.76 _____
No 67 65
DM     
Yes 12 10
0.23 0.66 _____
No 87 90
Cirrhosisofliver/Liverfailure   
Yes 3 3
1.74x10Ͳ4 1.00 _____
No 96 97
Chronicrenalfailure/CRI   
Yes 3 1
96.04 <0.0001 _____
No 96 99
19
Pancreatitis    
Yes 7 1
4.76 0.03 7.1:1
No 92 99
LungCancer    
Yes 3 1
1.04 0.37 _____
No 96 99
ColonCancer    
Yes 0 0
_____ _____ _____
No 99 100
Leukemia/lymphoma/hematologicmalignancy  
Yes 2 2
1.02x10Ͳ4 1.00 _____
No 97 98
Anemia     
Yes 15 18
0.29 0.70 _____
No 84 82
SeizureDz     
Yes 4 4
2.08x10Ͳ4 1.00 _____
No 95 96
Connectivetissuedisorder/RA/SLE.I  
Yes 1 0
1.01 0.50 _____
No 98 100
Sexualdysfunction    
Yes 2 0
2.06 0.25 _____
No 97 100
HSV/HZVInfection    
Yes 20 34
4.79 0.04 1:1.7
No 79 66
Cholecystitis/Cholelithiasis/GBDisease  
Yes 4 5
0.10 1.00 _____
No 95 95
OSA     
Yes 3 1
1.04 0.37 _____
No 96 99
Psoriasis     
Yes 3 3
1.74x10Ͳ4 1.00 _____
No 96 97
BPH     
Yes 4 2
0.71 0.44 _____
No 95 98
GERD     
Yes 22 33
2.89 0.11 _____
No 77 67
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Erectiledysfunction    
Yes 7 5
0.38 0.57 _____
No 92 95
Gout     
Yes 1 1
1.26x10Ͳ4 1.00 _____
No 98 99
Radiculopathy    
Yes 8 11
0.49 0.63 _____
No 91 89
Myopathy     
Yes 1 1
1.26x10Ͳ4 1.00 _____
No 98 99
Thrombocytopenia    
Yes 5 16
6.32 0.02 1:3.1
No 94 84
*AlthoughthenumberofPTSDdiagnosesmadenosignificantdifferencebetweenclinics,asexplainedintheresultsand
discussion,thevaluesforPTSDfromtheinitialunivariateanalysisareincludedinthischart,butthevaluesforpsychiatric
disorderaretheadjustedvalues.
Co-infections 
 As the purpose of this study was to determine what, if any, factors characterized VAMC 
HIV patients compared to a sympatric community population, three co-infections were 
considered: hepatitis C, hepatitis B, and syphilis (Table 5). Statistical analyses revealed that only 
cases of hepatitis C co-infection were significantly different between the clinics. The VAMC 
population had significantly more hepatitis C than the COM population (F2 = 12.56, df = 1, P 
<0.001). In fact, VAMC patients were 3.00 times more likely to be co-infected with hepatitis C 
(VAMC = 30%, COM = 10%) (Table 5). 
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Table5.CoͲinfectionsofVAMCandCOMHIVPatients
 VAMC* COM* F Pvalue RelativeRisks(VAMC:COM)
HepatitisC     
Yes 30 10
12.56 0.0006 3.0:1
No 68 88
HepatitisB     
Yes 6 9
0.62 0.59 _____
No 91 89
Syphilis     
Yes 13 9
1.09 0.37 _____
No 77 86
*ThenumbersofVAMCandCOMpatientsvaryfromtheclinictotalsbecausesuchinformationwas
unattainable.
Mortality 
Fortunately, neither population had a high mortality rate. As 13% of the VAMC patients 
passed away during the study versus 1% of COM patients, the VAMC had a higher mortality rate 
than the COM, with patients being 13.13 times more likely to pass away during the time-frame 
of the study (F2 = 11.19, df = 1, P = 0.0006) (Table 6). 
Table6.MortalityRateofVAMCandCOMHIVPatientsDuring
theStudy
 VAMC COM F Pvalue RelativeRisks(VAMC:COM)
MortalityRate    
Passed
away 13 1 11.19 0.0006 13.1:1
Stillliving 86 99
Multivariate Analysis 
Of all the variables examined in the study, only eight were of significance in the 
multivariate analysis and were included in the final model. Of the eight factors, three were 
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demographic (age, gender, and heterosexuality), two were habits posing potential health risks 
(cocaine use and alcohol use), two were co-morbidities (pancreatitis and thrombocytopenia), and 
one was a co-infection (syphilis) (Table 7). Only one (thrombocytopenia) added to the model’s 
efficacy marginally. None of the results were sensitive to changes in the inclusion or removal 
criteria values used with the forward STEPWISE SELECTION option in the PROC LOGISTIC 
regression of SAS.
16
Additionally, when the backward STEPWISE SELECTION option was 
performed on the model, there was no change in results. Moreover, there were no significant 
interactions between any of the variables included in the models. 
Table7.ResultsofMultivariateAnalysisComparingFactorsAssociatedwithHIV
PatientsattheVAMCandCOM
Effect df F Pvalue OddsRatio(VAMC:COM)
Age 1 46.71 <0.0001 mean=50.0years,s.d.=8.84:mean=37.9years,s.d.=9.75
Cocaine 1 11.82 <0.001 6.0:1
Gender 1 12.18 <0.001 8.5:1
Heterosexual 1 5.46 0.02 4.1:1
Pancreatitis 1 6.29 0.01 7.5:1
Alcohol 1 6.78 0.01 1.4:1
Syphilis 1 4.40 0.04 1.6:1
Thrombocytopenia 1 4.05 0.04 1:3.6
CD4 Cell Count and Viral Load 
 Repeated measures ANOVA showed no significant differences in CD4 cell count either 
at the first or last patient visit. However, a strong correlation between CD4 cell counts on first 
and last visits was identified such that the patients who had the higher CD4 cell counts initially 
also tended to have high CD4 cell counts at their last visit, regardless of which clinic the patient 
was from. Furthermore, a significant interaction between clinics and CD4 cell counts indicated 
that CD4 cell counts rose more rapidly in the COM population (Table 8, Figure 1). 
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Table8.ResultofRepeatedMeasuresANOVAforCD4CellCounts
TakenonFirstandLastPatientVisits
Source df Fvalue Pvalue
Clinic 1 0.01 0.91
CD4 1 24.19 <0.0001
ClinicxCD4 1 4.98 0.03
Error 145 ͲͲͲͲͲ ͲͲͲͲͲ
   
 Similarly, no significant differences in viral load were found between clinics. However, 
there were significant differences in the first and last viral load measurements, but, in contrast to 
CD4 cell counts, there was no strong correlation between first and last viral loads. It can be 
inferred from Figure 2 that the rate accounts for the difference in first and last measurements, but 
the clinics themselves have nearly the same slope indicating similar rates of decrease in viral 
loads (Table 9, Figure 2). 
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Table9.ResultofRepeatedMeasuresANOVAforViralLoad(VL)
TakenonFirstandLastPatientVisits

Source df Fvalue Pvalue
Clinic 1 2.26 0.14
VL 1 16.39 <0.0001
ClinicxVL 1 1.00 0.32
Error 142 ͲͲͲͲͲ ͲͲͲͲͲ
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Discussion 
 Studies of HIV/AIDS in rural areas are relatively rare. One of the first such studies was 
conducted in 1989 in Johnson City, TN.
3
 The clinic the 1989 study was based on was, in effect, 
replaced by the Tennessee HIV Center of Excellence clinic established in Johnson City in 1999. 
It was this clinic which provided the patient sample analyzed in this study. So, although our 
study involved a clinic other than the one in the 1989 study, we were still presented with a 
unique opportunity to research HIV in the same locale 21 years after the initial study. The former 
study was an anecdotal one in which three physicians specializing in infectious diseases were 
asked to discuss their experiences with HIV/AIDS in a rural area. It was noted that gay white 
males constituted the largest portion of the COM clientele and that, “[a]s of June 1989[,]…[they 
had] seen 81 [HIV] infected patients.” 
3
 Twenty-one years later, the COM population still 
predominantly consists of white males whose risk factor(s) include having sex with men. 
However, now the number of HIV/AIDS patients seen in this area—both at the VAMC and 
COM—exceeds 600,
11
coinciding with the observation that, “[w]hile rural AIDS incidence is still 
low compared to urban, it has been rising considerably faster since 1988-89.” 
6
 In a hopeful 
concluding statement, the authors mentioned that “[i]f our findings of a low prevalence of HIV 
seropositivity among gay men in nonurban areas is true of other rural areas as well, a ‘window of 
opportunity’ presents itself for targeted educational efforts aimed at preventing spread of HIV 
infection.”
3
However, from the results of this and other studies, it appears that this “window of 
opportunity” was not taken advantage of, as the prevalence and characteristics of HIV in this and 
other rural areas have dramatically changed since 1989. 
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Findings of High Significance 
 The most noteworthy findings from this study were the differences in demographic 
features (age, gender, race, sexual preference), habits (drug usage), and co-infections (syphilis, 
HCV) of the patients from the two clinics. The median age at the VAMC of 50 years, with a 
range from 32 to 76 years, and at the COM the median age of nearly 38 years, with a range from 
16 to 67 years, were quite similar to patient age ranges in other study populations. For example, a 
study on the US-Mexico border reported a mean age of “35 years, with a range of 19 to 71,” 
5
while another study looking at four American cities in the Southeast recorded a mean age of “36 
years (range, 19 to 75 years)” for male participants and of “33 years (range, 18 to 67 years)” for 
females.
2
A nationwide VA study that assessed National Quality Forum performance measures 
specific to HIV/AIDS treatment “using available electronic data for the large, diverse population 
with HIV in the” VA revealed a mean age of 52.5 years, with an interquartile range from 46.3-
58.8 years.
17
Our results also coincided with a finding of another study that looked only at a 
veteran cohort: “HIV-infected veterans tend to be older…[compared to] the non-veteran HIV-
infected population with similar characteristics.”
 10 
Furthermore, a study performed in America 
that researched characteristics of rural AIDS patients within each of the four Census Bureau 
regions notes that “[r]ates within each MSA [Metropolitan Statistical Area] and region category 
were highest for people 30 to 49 years of age at diagnosis, followed by people 13 to 29 years of 
age and people 50 to 64 years of age, and were lowest for people older than 65 years of age at the 
time of AIDS diagnosis.” 
1
 The mean ages of the current study very nearly fit within the most 
populous range cited in that study. However, it should be noted that each of the other studies had 
different times at which they recorded participants’ ages (i.e., at the time of an interview, at the 
time of diagnosis, etc.).  
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In the current study, patients from both populations were predominantly male and 
Caucasian although more African-Americans were noted at the VAMC. Nearly every other 
related study also consisted mainly of male HIV/AIDS participants.
1- 2, 4-5, 7-8, 17
Conversely, most 
other studies of HIV/AIDS in predominantly rural America noted that the majority of 
participants were African-American,
1, 2, 7
 but the issue of race/ethnicity appears to be much more 
region-specific. For example, Hispanics made up the largest racial group in a study of HIV/AIDS 
patients on the US-Mexico border, followed by white non-Hispanics and then African-
Americans.
5
The study that focused on rural areas within the four regions of the United States 
concluded that “AIDS rates differ by race…; however, some patterns are evident…. Rates for 
blacks are 3 to 32 times higher than rates for whites; rates for Hispanics fall between those for 
blacks and whites in nearly every location.” 
1
Conclusions from a number of studies support the hypothesis of HIV/AIDS spreading to 
rural America in two waves, the second of which is “homegrown” and considered to consist 
primarily of young, non-white women.
2, 4, 6
 A review paper of all HIV/AIDS studies performed 
in rural America up to December 1995 states:  
Rural HIV/AIDS is distributed unevenly, with 30 percent of cases concentrated in the 
South Atlantic states. Rural HIV/AIDS rates are particularly high among Black 
women, adolescents, Native Americans, and migrant workers. Rural [persons living 
with AIDS] are more likely to be female, heterosexual, non-White, and young. 
Intravenous drug use…and heterosexual contact are emerging as important modes of 
transmission. Individuals infected in urban locales who migrate to rural areas 
account for a substantial number of local cases.
6
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  The findings in the current study clearly differ from the observations described above.  In 
our study, a large number of patients were Caucasian men, a lot of whom were homosexual. Of 
the 199 patients involved in the study, only 24 were women (3 VAMC; 21 COM). Of those, 13 
were Caucasian (1 VAMC; 12 COM) and 9 were African-American (1 VAMC; 8 COM), a racial 
makeup that differs not only from that reported in other studies
2, 4, 6
 but also from that of the 
local area. As of 2009, African-Americans were recorded as comprising 4.1% of the Washington 
County population and 16.8% of the state of Tennessee.
14 
The fact that African-Americans 
composed 38% of the VAMC population and 11% of the COM shows the racial makeup of both 
local HIV populations differs from the general population, a result that is consistent with 
literature that ascertains the high prevalence of HIV infection among certain racial/ethnic 
groups.
1, 2, 7
 In the current study, ages of the females varied, so they could not be categorized as 
primarily young or old. However, the predominant mode of transmission for female patients was 
heterosexual contact (20 out of 24); only one female patient (COM) was noted to have IVDU as 
a risk factor. 
The review paper mentioned that “IV drug use is a major contributor to the distribution of 
HIV infection in women, but there may be regional variation, as yet unexplained.” 
6
 The results 
of the current study support the hypothesis of regional variation since IVDU was not a major 
contributor to HIV infection in females. Other studies have had similar findings; for example, the 
regional study of America noted that “[e]xposure categories for women differed little between 
regions, races or size of MSA. Within each race group, the proportion of cases with injection 
drug use as the risk category was highest in the larger MSAs and similar in the smaller and non-
MSAs…In all other race, region and MSA size categories, the proportion of cases among women 
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due to heterosexual contact either exceeded injection drug use or was comparable; no patterns 
were discernible.” 
1
In the univariate analysis of the current study, two risk factors (MSM and IVDU) differed 
significantly between the VAMC and the COM, but neither proved significant in the multivariate 
analysis. A study examining rural areas and small cities of four southeastern states notes that 
“[m]ost [of the 608] respondents had been infected through sexual contact (67 percent of men, 66 
percent of women)…. Before HIV infection was diagnosed, high-risk sexual behavior and drug 
use were common among both men and women.” 
2
It should be noted that that study did not 
differentiate between heterosexual and homosexual contact. However, it is noteworthy that the 
current study—in both univariate and multivariate analyses—shows significant differences in 
rates of heterosexual contact between the VAMC and COM.  
A regional study of the geographic distribution of AIDS in the United States says of 
MSM: “Except in the Northeast, within each race and region, the proportion of men who 
reported sex with men as their risk exposure was greatest in the larger MSAs (range, 39 percent 
to 76 percent), lower or the same in the smaller MSAs (36 percent to 72 percent), and lowest in 
the non-MSAs (39 percent to 67 percent), although some of the differences were small.” 
1
Furthermore, a study concerned with HIV/AIDS in medically underserved rural areas of America 
(Appalachia, Mississippi Delta, US-Mexico Border, Southeast Region) stated that “[i]n all 
regions, most people with a diagnosis of HIV were male, and the primary mode of exposure 
among men was sex with men. However, a larger proportion of men in the Southeast Region 
were exposed through heterosexual contact (28.5%) than were men in other regions (18.4% in 
the Mississippi Delta, 13.8% in Appalachia, and 8.0% at the US-Mexico Border).” 
7
 Because the 
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VAMC clinic most likely serves a wider region than the COM clinic, the results of the current 
study showed that heterosexual contact was a prevalent mode of transmission for infected 
VAMC male patients. 
Of the 199 patients studied, only 31 were noted to have IVDU as a risk factor (23 
VAMC; 8 COM). Thirty of these were males, 14 of whom were Caucasian (7 VAMC; 7 COM) 
and 16 African-American (16 VAMC). These results are consistent with those of other studies.
1, 4
For instance, the regional study of the United States noted that “[t]he proportion of cases among 
male injection drug users was considerably lower among whites than the other racial/ethnic 
groups and higher in the Northeast than the other regions.” 
1
Thus, the racial/ethnic factor of the 
statement is comparable to the results of the current study, and, since the current study was 
performed in the South, so is the regional factor. One possible explanation given for the 
racial/ethnic discrepancy related to IVDU is simply that high-risk behavior is currently more 
characteristic of certain ethnicities than others, just as rural homosexual men have been notably 
slower than their urban counterparts to begin practicing safe sex.
6
 Regional variances in risk 
factors have been observed in other studies and are attributed to “differences in IV drug use, 
sexual behavior, and levels of sexually transmitted diseases” (STDs).
6
Not surprisingly, a number of researchers have observed a correlation between HIV 
infection and STDs in rural areas. Two HIV/AIDS studies were conducted in Georgia. One was a 
“seroprevalence assessment of 1,309 hospital patients in rural Georgia[; it] found a majority of 
those testing HIV-positive were also positive for at least one sexually transmitted disease.” 
6
The
other focused on HIV-positive individuals who were also users of IV drugs. The results revealed 
that a significant number of those individuals—both in rural and urban areas—were co-infected 
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with syphilis.
6
 A regional study of rural America states that “[t] here are some communities with 
relatively high AIDS rates, especially those that have been affected by interacting epidemics of 
sexually transmitted diseases and drug use.” 
1
 Another study concentrating on rural America 
concedes that, within the “homegrown” wave of rural infection, “[s]exual acquisition of HIV 
infection was predominant…[but o]ther factors associated with HIV transmission in rural areas 
are high rates of [STDs] and alcohol and other drug abuse.” 
2
Most likely, this correlation between HIV infection and STDs is a reflection of sexual 
behavior within regions. As one example, “[t]esting from 1988 to 1990 in rural Mississippi, a 
State Department of Health STD clinic yielded a [HIV] seroprevalence rate of 4.0 per 1,000 
among 9,855 adolescents treated for sexually transmitted disease. The rate for females nearly 
equaled that of males, and the rate for adolescents from counties with populations below 25,000 
was equivalent to that of counties over 100,000. Overall, rural Black adolescents had rates 3.5 
times higher than Whites.” 
6
 The Mississippi Delta Region is known for its high prevalence of 
HIV among African-Americans, and especially adolescents, so it is not surprising that such high 
rates of STDs are also found within those populations.
7
Interestingly, syphilis—the only STD 
included in the logistic regression model of the current study—showed no significance in the 
univariate analysis, but it was significant in the multivariate analysis. There was not a large 
majority of patients co-infected with syphilis (13 VAMC; 9 COM), but the results of the 
multivariate analysis coincide, to a lesser degree, with those of these other studies. 
Despite the fact that HCV did not meet the criterion necessary to be included in the 
multivariate logistic regression model, the univariate analysis showed a significant difference 
between the two clinics in HCV co-infection (30 VAMC; 10 COM). Explanations as to why 
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HCV was not included in the logistic regression model are not fully understood at this point. 
However, it is plausible that the larger proportion of HIV/HCV co-infected persons at the 
VAMC can be explained by the larger incidence of cocaine use and also of IVDU characteristic 
of that population (cocaine use: 37 VAMC, 9 COM; IVDU: 23 VAMC, 8 COM). 
To our knowledge, this is the first study of HIV/AIDS in rural America to include 
information on habits posing potential health risks. Of the six habits considered, four showed 
significant differences between clinics in the univariate analysis (use of cocaine, marijuana, and 
tobacco and participation in habits categorized as “other”). Of these, only one (use of cocaine) 
was included in the multivariate logistic regression model. Interestingly, another habit (use of 
alcohol) was included in the model even though it showed no significant differences between 
populations in the univariate analysis because of its near identical prevalence at the clinics (45 
VAMC; 38 COM). A reasonable assumption is that alcohol use is so correlated with pancreatitis 
that it met the inclusion and removal criteria of the multivariate model, but other explanations 
could exist. Regardless, results of the current study reveal that alcohol and, especially cocaine, 
use are distinguishing factors between the VAMC and COM populations. 
A majority of the literature on HIV/AIDS in rural America associates CD4 cell counts 
and measures of viral load with reasons for patient migration and/or with adherence to office 
visits.
4, 6, 8
 Unfortunately, due to time constraints, available data concerning patient migration and 
compliance to office visits over a consecutive three-year period were not analyzed. Despite this, 
the results of the paired t-test for CD4 cell count and viral load had significant implications for 
the study populations. The fact that the COM population, which consisted of younger patients 
compared to that of the VAMC, had a lower initial CD4 cell count was surprising and indicative 
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of treatment being sought late. However, this same factor of COM patients being, on average, 
younger than VAMC patients may account for the COM population’s CD4 cell count rising at a 
faster, though not significantly faster, rate to become the highest of the two counts at patients’ 
last visits.  
A VA study conducted to evaluate the one-year survival of a group of immunosuppressed 
(CD4 <100) HIV-infected veterans divided the group into three cohorts based upon the time they 
entered the study: pre/early [highly active antiretroviral therapy (HAART)], HAART, and 
current HAART. The study was conducted based on the knowledge that “[e]asier to take and 
more effective HAART options have improved the one year virologic success rate among naïve 
patients. Numerous studies have shown that initiating HAART and restoration of CD4 cells 
positively impact survival.” 
10
 Although this study, which was one of few that also included co-
morbidities, focused on the survival of immunosuppressed HIV-infected veterans while the 
current study focused on describing the profiles of rural HIV-infected patients at a VAMC and a 
COM clinic, some results of the studies are comparable.  
For example, the VA study found that “[o]lder age at time of entry into the cohort, and 
having a diagnosis of lymphoma…CAD, or renal insufficiency had a negative impact [on 
survival].”
10 
Although neither CAD nor chronic renal failure/chronic renal insufficiency were of 
statistical significance in the current study (CAD: 11 VAMC; 4 COM and chronic renal 
failure/CRI: 3 VAMC; 1 COM), VAMC patients were older than COM patients (mean age: 50 
years VAMC; 38 years COM) and had a higher mortality rate (13 VAMC; 1 COM). Therefore, it 
could be supposed that these factors explain why the VAMC population had a smaller increase in 
CD4 cell count from first patient visit to last. However, due to several reasons, one of which is 
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the different criterion of inclusion in the studies, this is only a weak postulation; more research 
would need to be performed before making any conclusions. It is more likely that the age of 
VAMC patients alone accounts for the insignificantly smaller rise in CD4 cell count because, 
“[a]s patients age with HIV and/or enter care at older ages, the effect of aging on survival will 
become even more relevant [than normal].” 
10
Another likely reason for this difference is that the 
VAMC dataset had more missing data than did the COM dataset because of less compliance to 
office visits, but further analyses are needed to ascertain whether VAMC patients did have a 
significantly lower level of compliance to office visits. Finally, considering the age and change 
of CD4 cell count between first and last patient visits of the COM population, another conjecture 
is that the COM patients had a better response to treatment because they were treatment naïve, 
but it is not known how many of the patients at either population were treatment naïve. 
All the conjectures made concerning the observed increases in the VAMC and COM 
CD4 cell counts during the study could also account for the decreases in viral load, which was 
lower for VAMC patients compared to COM patients at both the first and last patient visits. A 
number of studies have shown that “HAART use, virologic suppression [VL <400], and 
improved CD4 cell count [CD4 >200] were major determinants of survival.” 
10
 However, 
another study discusses the difficulty of controlling viral load, saying that, although it is 
“important for reducing patient morbidity and mortality from HIV/AIDS...In practice, this rate is 
constrained by the limitations of available medical therapy. Health care providers cannot prevent 
unacceptable adverse effects that require discontinuation of a medication, nor can they directly 
alter the ability of the virus to develop resistance. Shared toxicity and resistance patterns among 
antiretrovirals mean that fewer combinations are available after the first, second, or third 
regimen.” 
17
 Thus, to reiterate, the fact that the COM population’s CD4 cell count rose faster to 
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become the higher of the two at the last visit while the COM population’s consistently higher 
viral load steadily decreased from first to last visit at nearly the same rate as the VAMC’s, could 
be indicative of a number of things that can only be elicited by further study but is mostly likely 
a result of the difference in age of the study populations. 
Findings of Lesser Significance 
There were some variables that showed significant differences between the VAMC and 
COM clinics, but these differences were of lesser significance because they were expected given 
the differences in the demographics and habits outlined in the previous section. Very few—if 
any—studies concerned with characterizing rural HIV/AIDS patients have looked at co-
morbidities. A study of the one-year survival rate of immunosuppressed HIV-infected veterans 
included data on several co-morbidities such as “coronary artery disease (CAD), chronic 
obstructive pulmonary disease (COPD), depression, diabetes mellitus, anal carcinoma, and renal 
insufficiency.”
10
In that study, “[c]o-morbidities were recorded if they were present at baseline 
or at any time during the follow-up period;” similarly, the current study recorded co-morbidities 
if they were present anytime between the patient’s first visit and December 2009, when the study 
ended.
10
Unlike the VA study, the current study focused on finding what, if any, factors are more 
characteristic of the VAMC population than the COM population and included 32 co-
morbidities. Of the six that showed a significant difference between the clinics in the univariate 
analyses (PTSD, CHF, asthma, pancreatitis, HSV/HZV, and thrombocytopenia), only two were 
included in the multivariate logistic regression model (pancreatitis and thrombocytopenia). 
Once PTSD was adjusted by including it as a psychiatric disorder (since a diagnosis with 
PTSD of any COM patient is highly improbable even if the symptoms existed), rates of 
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psychiatric disorders no longer showed a significant difference between the two study 
populations. This finding is in contrast to a study performed within a VA population (which also 
included PTSD as a psychiatric disorder) that reported “results from this study could be 
generalized to the non-veteran HIV-infected population with similar characteristics. Although 
HIV-infected veterans tend to…[have] more medical and psychiatric co-morbidities than the 
general US HIV-infected population, after adjustment for medical and psychiatric co-
morbidities, the clinical outcomes among HIV-infected veterans are similar overall to other HIV 
cohorts” because the results of the current study indicate no such adjustments are necessary 
(Psychiatric disorders: 60 VAMC; 66 COM).
10
Perhaps HIV/AIDS patients are more prone to 
having psychiatric disorders (particularly depression or anxiety) as a result of infection and have 
a higher prevalence compared to the general population, but certainly no evidence exists in the 
current study to ascertain a significant difference between the VAMC and COM HIV 
populations as far as this co-morbidity is concerned. 
Because the VAMC population consisted mainly of comparatively older males with 
tobacco use common, it was not surprising that CHF was significantly more prevalent in that 
population. The fact that this co-morbidity was not significant in the multivariate model could be 
indicative of CHF being more correlated with older males than HIV-infection and thus age alone 
was a more efficient predictor than both age and CHF. Similarly, asthma showed significance in 
the univariate analysis but did not meet the criteria to be included in the multivariate model. This 
is likely more due to the United States Armed Forces not allowing anyone with asthma to serve 
rather than to an association existing between the co-morbidity and HIV-infection. 
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Herpes simplex and herpes zoster viruses were included in the study because we wanted 
to include as many co-morbidities as possible to uncover potential relationships within the 
observed populations. While a form of HSV can be contracted sexually, another is congenital. 
Likewise, HZV is not sexually transmitted. Thus, it was not surprising when HSV/HZV were not 
considered significant predictors in the multivariate model. 
As for pancreatitis and thrombocytopenia, which proved significant in both univariate 
and multivariate analyses, it is thought that they could be associated with disease progression. It 
is known that “[a]lcohol abuse is an important contributor to HIV disease progression,” 
8
so it 
does not seem unlikely that pancreatitis—independently associated with alcohol abuse—could 
act in the same way. Furthermore, just as pancreatitis was more prevalent at the VAMC (7 
VAMC; 1 COM), so was alcohol use (45 VAMC; 38 COM) though the difference was small. 
Because of the adverse effects HIV/AIDS takes on the body’s immune system, it also does not 
appear implausible to suggest that thrombocytopenia could be associated with disease 
progression. However, why this co-morbidity was more prevalent among COM patients (5 
VAMC; 16 COM) is not known. Typically, thrombocytopenia is seen early in HIV infection and 
is subsequently resolved with treatment. The data could be analyzed further to determine when in 
a patients’ treatment he/she was diagnosed with and treated for thrombocytopenia. Regardless, 
further research should be conducted before making any conclusions concerning these 
postulations. 
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In conclusion, several characters were identified that distinguish HIV patients at the 
Mountain Home, TN VAMC from similar patients at the COM in the same rural area (Figure 3). 
These include age, gender, heterosexuality, cocaine and alcohol use, pancreatitis, 
thrombocytopenia, and a co-infection with syphilis. With the exception of thrombocytopenia, all 
are more characteristic of VAMC HIV patients. 
Despite not meeting the criterion of the multivariate logistic regression model, both race 
and HCV co-infection showed significant differences in the two study populations in the 
univariate analysis and have important implications in the study. While the racial makeups of the 
two clinics differ, neither the VAMC nor the COM population reflects the racial makeup of the 
local general population; instead, both have larger percentages of African-Americans, as 
previously discussed. Plans for further evaluation of the issue of racial differences between the 
clinics and the clinics versus the local general population are being made. 
While certain limitations exist within the study, such as the possibilities of inaccurate 
self-reporting—especially in the case of risk factors—and an uneven distribution of racial/ethnic 
populations in the area (i.e., patients were predominantly either Caucasian or African-American), 
Figure 3.  Summary of Factors That Differ Significantly 
Between the VAMC and COM Patient Populations
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these are common problems encountered in nearly every HIV/AIDS study focused on a single 
region and would likely have no effect on the accuracy of the results of this study. Having only 
99 patients at the VAMC to include in the study may be considered a limitation as well, but 
considering that is the entire population, it was the only way to conduct the study.
 Although the AIDS epidemic began in America well over two decades ago, relatively 
little is known about HIV/AIDS in rural areas compared to urban areas, and what studies have 
been conducted have focused primarily on individual regions as opposed to the nation as a 
whole. Furthermore, this is one of the few studies—if not the first—that has compared profiles of 
HIV patients at a VA facility to a community one. While these studies have been instrumental in 
profiling parts of the nation and even certain minorities apparently more prone to HIV infection 
than others, such as the African-American, Native American, Native Alaskan, and Hispanic 
populations,
2, 6, 7, 8
 much more work is needed to uncover the full “face” of HIV/AIDS in rural 
America. 
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